1 Department of Ophthalmology, University of Tokyo School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan 2 Department of Materials Engineering, School of Engineering, The University of ...
Purpose To quantitatively explore preretinal abnormal tissue (PAT) in macula-on rhegmatogenous retinal detachment (RRD) before and after surgery. Methods In this case-series study, PAT was detected by ...
Taraprasad Das, MD, L V Prasad Eye Institute, Road #2, Banjara Hills, Hyderabad 500 034, India. AIM To evaluate the efficacy of intravitreal dexamethasone co-administered with intravitreal antibiotics ...
AIMS To calculate the diameter of halos perceived by patients with multifocal intraocular lenses (IOLs) and to stimulate halos in patients with refractive multifocal IOLs in a clinical experiment.
Devron H Char, MD, Tumori Foundation, Suite 309, CPMC-Davies, 45 Castro Street, San Francisco, CA 94114, USA. AIM To evaluate retrospective data on the clinical findings, histological features, ...
Use of immunomodulatory treatment for non-infectious uveitis: an International Ocular Inflammation Society report of real-world practice ...
Purpose To analyse the effects of intravitreal dexamethasone implant in patients suffering from diabetic macular oedema (DME) on the basis of their visual and functional response to antivascular ...
Correspondence to Maurizio Rolando, Ocular Surface Unit, ISPRE Genova, Genoa, Italy; maurizio.rolando{at}gmail.com Dry eye disease (DED) is a growing public health concern affecting quality of life ...
5 National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK Correspondence to Professor Jugnoo S ...
Correspondence to Dr Irmela Mantel, Department of Ophthalmology, University Eye Hospital Jules Gonin, 15 Av. de France, Case postale 133, CH-1000 Lausanne 7, Switzerland; irmela.mantel{at}fa2.ch Aims ...
Aims To demonstrate non-inferiority of ranibizumab treat-and-extend (T&E) with/without laser to ranibizumab pro re nata (PRN) for best-corrected visual acuity (BCVA) in patients with diabetic macular ...
a Ocular Surface and Tear Center, Department of Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida, USA, b Department of Cell Biology and Anatomy, University of Miami School of Medicine, Miami ...